Patent ID: 11931410
Assignee: SHENZHEN RHEGEN BIOTECHNOLOGY CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 8:
9. The mRNA molecule according to claim 8, wherein the 3′ tailing modification includes a poly-A tail, and the poly-A tail is a polyadenosinic acid with or without a linker inserted therein;
the cap structure in the at least one 5′ capping modification is selected from Cap0, Cap1, ARCA, inosine, N1-methyl-guanosine, 2′-flurorine-guanosine, 7-deaza-guanosine, 8-oxy-guanosine, 2-amino-guanosine, LNA-guanosine, or 2-azido-guanosine.